Thiard News@F4F

@newsen.bsky.social

3 months ago

Co-Diagnostics JV CoSara Expands Distributor Network by Attending Key Conferences in India Co-Diagnostics' joint venture CoSara strengthens its distributor network in India by participating in regional conferences to promote diagnostic products.

Co-Diagnostics JV CoSara Expands Distributor Network by Attending Key Conferences in India #India #Mumbai #Molecular_Diagnostics #Co-Diagnostics #CoSara_Diagnostics

Thiard News@F4F

@newsen.bsky.social

4 months ago

Seegene Strengthens Its Position in Europe with New French Subsidiary Seegene, a leader in molecular diagnostics, has launched a new subsidiary in France, boosting its European presence and aiming to enhance local market engagement.

Seegene Strengthens Its Position in Europe with New French Subsidiary #None #France #Molecular_Diagnostics #Seegene

Thiard News@F4F

@newsen.bsky.social

4 months ago

Seegene Launches New Subsidiary in France to Expand European Market Presence Seegene, a leader in molecular diagnostics, has established a new subsidiary in France to enhance its presence in Europe and broaden customer engagement.

Seegene Launches New Subsidiary in France to Expand European Market Presence #Paris #France #Molecular_Diagnostics #Seegene

Thiard News@F4F

@newsen.bsky.social

4 months ago

Seegene Expands European Presence with New Subsidiary in France Seegene, a leader in molecular diagnostics, has announced the establishment of a new subsidiary in France to enhance its market presence and support healthcare partnerships.

Seegene Expands European Presence with New Subsidiary in France #France #N/A #Molecular_Diagnostics #Seegene #CURECA

Thiard News@F4F

@newsen.bsky.social

5 months ago

Fapon to Present Revolutionary Molecular Diagnostic Solutions at AMP 2025 Annual Meeting in Boston Fapon will unveil advanced molecular diagnostic solutions, including AI-driven enzymes, at the upcoming AMP 2025 Annual Meeting from November 11-15 in Boston.

Fapon to Present Revolutionary Molecular Diagnostic Solutions at AMP 2025 Annual Meeting in Boston #USA #Boston #Molecular_Diagnostics #Fapon

Thiard News@F4F

@newsen.bsky.social

5 months ago

Point-of-Care Molecular Diagnostics Market Projected to Reach $15.2 Billion by 2033 The Point-of-Care Molecular Diagnostics market is set to grow significantly, reaching $15.2 billion by 2033, driven by innovations in healthcare technology.

Point-of-Care Molecular Diagnostics Market Projected to Reach $15.2 Billion by 2033 #None #Market_Growth #healthcare_technology #Molecular_Diagnostics

Thiard News@F4F

@newsen.bsky.social

5 months ago

Co-Diagnostics Closes $7 Million Stock Offering to Boost Operations and Growth Co-Diagnostics, Inc. recently closed a $7 million stock offering to support its growth and operational activities, enhancing its molecular diagnostics capabilities.

Co-Diagnostics Closes $7 Million Stock Offering to Boost Operations and Growth #United_States #Salt_Lake_City #Molecular_Diagnostics #Co-Diagnostics #CODX

Thiard News@F4F

@newsen.bsky.social

5 months ago

Co-Diagnostics, Inc. Announces $7 Million Direct Offering and Future Plans Co-Diagnostics, Inc. has announced a $7 million registered direct offering of common stock, aiming to enhance its molecular diagnostics operations. The offering price is set at $0.55 per share.

Co-Diagnostics, Inc. Announces $7 Million Direct Offering and Future Plans #USA #NASDAQ #Salt_Lake_City #Molecular_Diagnostics #Co-Diagnostics

Thiard News@F4F

@newsen.bsky.social

6 months ago

Co-Diagnostics, Inc. Engages Investors at the Fall 2025 Conference Co-Diagnostics, Inc. will present at the Lytham Partners Fall 2025 Investor Conference, focusing on its innovative molecular diagnostic technologies.

Co-Diagnostics, Inc. Engages Investors at the Fall 2025 Conference #United_States #Salt_Lake_City #Molecular_Diagnostics #Co-Diagnostics #Lytham_Partners

Thiard News@F4F

@newsen.bsky.social

6 months ago

Co-Diagnostics, Inc. Raises $3.8 Million through Direct Stock Offering to Accelerate Growth in Molecular Diagnostics Co-Diagnostics, Inc. has successfully completed a direct offering, raising $3.8 million to enhance its molecular diagnostics capabilities. This funding aims to support their growth and innovation.

Co-Diagnostics, Inc. Raises $3.8 Million through Direct Stock Offering to Accelerate Growth in Molecular Diagnostics #United_States #Salt_Lake_City #Molecular_Diagnostics #Co-Diagnostics #CODX

Thiard News@F4F

@newsen.bsky.social

6 months ago

Co-Diagnostics, Inc. Unveils $3.8 Million Common Stock Offering Under Nasdaq Guidelines Co-Diagnostics, Inc. has announced a direct offering of $3.8 million in common stock at an attractive price, aiming for growth and innovation in molecular diagnostics.

Co-Diagnostics, Inc. Unveils $3.8 Million Common Stock Offering Under Nasdaq Guidelines #United_States #NASDAQ #Salt_Lake_City #Molecular_Diagnostics #Co-Diagnostics

Thiard News@F4F

@newsen.bsky.social

7 months ago

The Ligase Enzymes Market: Projected Growth and Key Trends Through 2030 The ligase enzymes market is set to grow significantly, valued at US$0.36 billion by 2030, driven by advancements in molecular diagnostics and synthetic biology.

The Ligase Enzymes Market: Projected Growth and Key Trends Through 2030 #USA #Delray_Beach #Molecular_Diagnostics #Next-Gen_Sequencing #Ligase_Enzymes

Thiard News@F4F

@newsen.bsky.social

7 months ago

Global Molecular Diagnostics Market Expected to Hit $30.74 Billion by 2030 The Molecular Diagnostics Market is forecasted to reach $30.74 billion by 2030, driven by innovations and increasing disease prevalence.

Global Molecular Diagnostics Market Expected to Hit $30.74 Billion by 2030 #United_States #Delray_Beach #Precision_Medicine #Molecular_Diagnostics #Genetic_Testing

Thiard News@F4F

@newsen.bsky.social

7 months ago

Co-Diagnostics, Inc. Reports Declines in Revenue and Operational Losses for Q2 2025 Co-Diagnostics, Inc. announces disappointing financial results for Q2 2025, reporting a significant drop in revenue and increased operational losses amidst ongoing developments.

Co-Diagnostics, Inc. Reports Declines in Revenue and Operational Losses for Q2 2025 #United_States #financial_results #Salt_Lake_City #Molecular_Diagnostics #Co-Diagnostics

Thiard News@F4F

@newsen.bsky.social

8 months ago

Molecular Diagnostics Market Projections: Expected to Reach USD 33.7 Billion by 2032 The Molecular Diagnostics market is set to soar, reaching USD 33.7 billion by 2032, driven by advancements in genomics and increased disease detection.

Molecular Diagnostics Market Projections: Expected to Reach USD 33.7 Billion by 2032 #None #Molecular_Diagnostics #Diagnostics_Market #SkyQuest

Thiard News@F4F

@newsen.bsky.social

9 months ago

In Situ Hybridization Market Expected to Reach $2.35 Billion by 2030: A Game-Changer in Molecular Diagnostics The in situ hybridization sector is set for substantial expansion, anticipated to reach $2.35 billion by 2030, transforming molecular diagnostics with innovative technologies.

In Situ Hybridization Market Expected to Reach $2.35 Billion by 2030: A Game-Changer in Molecular Diagnostics #USA #Delray_Beach #Precision_Medicine #Molecular_Diagnostics #In_Situ_Hybridization

Thiard News@F4F

@newsen.bsky.social

9 months ago

The In Vitro Diagnostics (IVD) Market Expected to Surpass $123 Billion by 2032 The In Vitro Diagnostics (IVD) market is projected to reach $123.28 billion by 2032, growing at a CAGR of 5.5% driven by advancements in technology and rising health awareness.

The In Vitro Diagnostics (IVD) Market Expected to Surpass $123 Billion by 2032 #None #Molecular_Diagnostics #Healthcare_Market #In_Vitro_Diagnostics

Thiard News@F4F

@newsen.bsky.social

9 months ago

HLA Typing Market Expected to Reach $1.7 Billion by 2030 Driven by Increasing Transplant Demand The HLA Typing Market is poised for substantial growth, projected to reach $1.7 billion by 2030, fueled by rising transplant demands and advancements in molecular diagnostics.

HLA Typing Market Expected to Reach $1.7 Billion by 2030 Driven by Increasing Transplant Demand #USA #Chicago #Molecular_Diagnostics #Transplantation #HLA_Typing

Thiard News@F4F

@newsen.bsky.social

9 months ago

Infectious Disease Testing Market Reaches $29 Billion Driven by Innovations in Point-of-Care Solutions The latest Kalorama report reveals the IVD market has soared to $29B, spurred by breakthroughs in molecular diagnostics and point-of-care testing.

Infectious Disease Testing Market Reaches $29 Billion Driven by Innovations in Point-of-Care Solutions #None #Molecular_Diagnostics #IVD_Market #Kalorama

Thiard News@F4F

@newsen.bsky.social

10 months ago

In Vitro Diagnostics Market Expected to Surpass $150 Billion by 2030 The In Vitro Diagnostics market is projected to reach $150.13 billion globally by 2030, driven by rising health demands and advancements in technology.

In Vitro Diagnostics Market Expected to Surpass $150 Billion by 2030 #USA #Chicago #Molecular_Diagnostics #Clinical_Chemistry #In_Vitro_Diagnostics

Thiard News@F4F

@newsen.bsky.social

11 months ago

Meridian Bioscience Launches Revolutionary Enzyme Stabilization Services for Enhanced Molecular Diagnostics Meridian Bioscience has unveiled new enzyme stabilization services, enhancing assay performance for molecular diagnostics, including qPCR and NGS.

Meridian Bioscience Launches Revolutionary Enzyme Stabilization Services for Enhanced Molecular Diagnostics #USA #Cincinnati #Molecular_Diagnostics #Meridian_Bioscience #Enzyme_Stabilization

Thiard News@F4F

@newsen.bsky.social

1 year ago

AMDI Revolutionizes Molecular Diagnostics with Launch of Autolab™ HBH System AMDI's new Autolab™ HBH system, unveiled at ESCMID 2025, promises faster and simpler sample preparation for molecular diagnostics in laboratories.

AMDI Revolutionizes Molecular Diagnostics with Launch of Autolab™ HBH System #USA #Vienna #Molecular_Diagnostics #Autonomous_Medical_Devices #Autolab™_HBH

Thiard News@F4F

@newsen.bsky.social

1 year ago

AMDI Unveils Revolutionary Autolab™ HBH System at ESCMID 2025 Conference Autonomous Medical Devices Incorporated presents the Autolab™ HBH, a game-changing technology for molecular diagnostics, at ESCMID 2025 in Vienna. Experience faster sample preparation with high efficiency.

AMDI Unveils Revolutionary Autolab™ HBH System at ESCMID 2025 Conference #United_States #California #Molecular_Diagnostics #Autonomous_Medical_Devices #Autolab_HBH

Thiard News@F4F

@newsen.bsky.social

1 year ago

Co-Diagnostics, Inc. Reveals 2024 Financial Outcomes and Future Strategies Co-Diagnostics, Inc. announces its financial performance for 2024, highlighting revenue changes, loss projections, and future strategy for diagnostics advancement.

Co-Diagnostics, Inc. Reveals 2024 Financial Outcomes and Future Strategies #USA #Inc. #Salt_Lake_City #Molecular_Diagnostics #Co-Diagnostics #Co-Primers

Thiard News@F4F

@newsen.bsky.social

1 year ago

The Surge of AI in Healthcare Diagnostics: A $8.9 Billion Growth Forecast The AI in Clinical and Molecular Diagnostics sector is set to surge from $2.6 billion in 2024 to $8.9 billion by 2029, reflecting a significant compound annual growth rate (CAGR) of 27.6%.

The Surge of AI in Healthcare Diagnostics: A $8.9 Billion Growth Forecast #United_States #Boston #Molecular_Diagnostics #AI_Healthcare_Diagnostics #Clinical_Diagnostics

Thiard News@F4F

@newsen.bsky.social

1 year ago

Global IVD Reagents Market Forecast to Reach USD 87.41 Million by 2029 Driven by Increased Demand and Innovation The IVD reagents market is set to increase from USD 60.45 million in 2024 to USD 87.41 million by 2029, reflecting a 7.7% CAGR. Innovations in diagnostics play a key role in this growth.

Global IVD Reagents Market Forecast to Reach USD 87.41 Million by 2029 Driven by Increased Demand and Innovation #USA #Healthcare_Innovation #IVD_Reagents #Molecular_Diagnostics #Delray_Beach,_Florida

Thiard News@F4F

@newsen.bsky.social

1 year ago

Molecular Diagnostics Market Expected to Surge by USD 7.92 Billion by 2028 Amid Rising Aging-Related Illnesses The molecular diagnostics market is poised for substantial growth, projected to expand by USD 7.92 billion from 2024 to 2028, influenced by age-related illnesses.

Molecular Diagnostics Market Expected to Surge by USD 7.92 Billion by 2028 Amid Rising Aging-Related Illnesses #United_States #New_York #Technavio #AI_Transformation #Molecular_Diagnostics